Project Grant HT9425261E291
Award Date 7/31/26
Completion Date 7/30/29
Dollars Obligated $583K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Charlottesville, VA, USA
Similar Awards
- Federal Grant Award Summary The University of Virginia received a $1.53 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) awarded on August 15, 2025, with a completion date of August 14, 2028. The award funds research investigating how melanoma-cognate T-cell help enhances survival outcomes in melanoma vaccine development. This research will be conducted at the university's Charlottesville, Virginia campus and...
- Federal Grant Award Summary The University of Virginia received a $5.54 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period September 30, 2025 through September 29, 2029. The award supports research and development of focused ultrasound interventions designed to provide noninvasive precision therapy approaches for treating primary and metastatic breast cancers. Research activities will be conducted at...
- Federal Grant Award Summary The University of Virginia received a $638,260 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded September 1, 2025, with completion scheduled for August 31, 2027. The award supports research titled "Linking Genetic, Metabolic, and Microenvironmental Predictors of Melanoma Metastatic Colonization," conducted at the university's Charlottesville, Virginia campus. This research...
- Federal Project Grant Award Summary The University of Virginia received an $858,608 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period of August 15, 2025 through August 14, 2028. The award supports research into understanding how melanoma-cognate T-cell help enhances survival outcomes in melanoma vaccine interventions. This research initiative contributes to the DHA's broader mission of advancing...
- Federal Project Grant Award Summary The University of Virginia received a $2.375 million project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded November 1, 2025, with a completion date of October 31, 2028. The grant funds research to develop an imaging biomarker for interface astroglial scarring in blast-exposed military personnel utilizing ultrahigh-gradient strength Magnetic Resonance Imaging (MRI) technology....
- Federal Grant Award Summary The University of Virginia received a $847,875 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the period of September 1, 2025, through August 31, 2028. The grant supports research focused on targeting Schwann cell-tumor microenvironment interactions in neurofibroma development. This three-year research initiative will be conducted at the university's Charlottesville, Virginia facility and...
- Federal Grant Award Summary The University of Virginia received a $3.2M Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective May 15, 2025 through May 14, 2029. The award supports the expansion of the Generalized Blast Exposure Value (GBEV) Tool, a research initiative designed to determine cumulative blast exposure thresholds in military populations. This project directly aligns with the DHA's mission to...
- The Defense Health Agency awarded a $1,592,860 Project Grant to the Rector & Visitors of the University of Virginia (UVA) on January 1, 2025 under the Military Medical Research and Development program (CFDA 12.420). The grant will support UVA's research to develop ultrasensitive proteomics techniques for predicting and assessing treatment efficacy for type 1 diabetes. This work aims to transform healthcare for military service members and the broader public by advancing innovative biomedical...
- Federal Project Grant Award Summary Vanderbilt University Medical Center (VUMC) received a $1.17 million Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to conduct research on optimizing lung cancer screening guidelines for all Americans. The award, obligated on July 31, 2026, supports a three-year research initiative extending through July 30, 2029, and will be performed at VUMC's Nashville, Tennessee location....
- Virginia Commonwealth University received a $1.84 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025 through August 31, 2028. The award supports the development and application of novel cell therapy as a treatment approach for advanced prostate cancer, addressing a medical condition relevant to Service Member health and the military population. The project is being conducted at VCU's...